Emulate, Inc.

ICYMI: This month, we heralded in the future of human-centric drug development with the launch of the AVA Emulation System, a first-of-its-kind high-throughput Organ-Chip platform. emulatebio.com/press/emulate-…

🧠 Introducing Brain-Chip R1 — the first isogenic, five-cell Organ-Chip model of the human NVU. A ready-to-use system for BBB transport + neuroinflammation research with results in 12 days. Learn more 👉 emulatebio.com/brain-chip/ #OrganChips #BBB #CNSResearch

What if we could predict a patient’s treatment response before they receive it? Organ-on-a-Chip technology offers a home away from home for patient-derived samples—revealing how cells truly respond to therapy. Full story 👉 emulatebio.com/using-organ-on… #PersonalizedMedicine

Join us for a live webinar where Dr. Ferri and Dr. Ingber will present the data and discuss what this means for the future of personalized medicine. 🗓️ October 30th, 2025 at 11:00 am EDT 🔗 Register: emulatebio.com/event/a-new-pa… #OrganChip #PersonalizedMedicine #NAMs

This breakthrough marks a major step toward functional precision medicine, where treatment decisions are guided by human-relevant models that mirror each patient’s unique biology. And it could revolutionize how we personalize cancer care.

Predicting how each individual patient will respond to cancer therapy has long been the holy grail of personalized medicine. A new study co-led by Dr. Lorenzo Ferri (McGill University) and Dr. Donald Ingber (Wyss Institute, Harvard) could change that. 👇

#DYK bone marrow is one of the organs most sensitive to radiation? AVATAR heading to deep space will contain bone marrow cells from @NASAArtemis II crew. Insights could advance personalized medicine, for both astronauts in space and patients on Earth. go.nasa.gov/4m5dGH9

Organ-Chips are boldly going where no chip has gone before! Emulate is teaming up with @NASAScience_ and @space_tango to support a first-of-its-kind experiment to send Organ-Chips into deep space aboard the Artemis II. Learn all about the program here: science.nasa.gov/biological-phy…

Regulators are calling for human-relevant data. 📊 Our CEO Jim Corbett shares how the new AVA™ Emulation System delivers scale + reproducibility to support FDA submissions and usher in a new era of #DrugDiscovery. 👉 Read more: emulatebio.com/insights-into-…

In our latest #blog, we're talking about the key US policy moves that are positioning #OrganChips and other New Approach Methodologies (#NAMs) to become the default alternatives to animal testing in drug development. emulatebio.com/alternatives-t… #drugdiscovery #sciencepolicy

This study revealed that cannabinoids have distinct, dose-dependent hepatotoxicity profiles, highlighting the importance of human-relevant models for cannabinoid safety evaluation. Read the full paper here: nature.com/articles/s4159…

Previous animal studies had conflicting or inconclusive results on the hepatotoxicity of cannabinoids; some showed no effects, while others showed signs of toxicity at high doses.

New publication alert! We’re excited to share the results of a recent collaboration with @Herbalife, now published in @SciReports! Using Emulate’s Quad-Culture Liver-Chip S1, this study explored the #hepatotoxicity potential of four common #cannabinoids—CBD, CBG, CBN, and CBC.

The newest edition of the Emulate Community Publications Digest is live! We're spotlighting all the recent research from our user community, from patient-matched cancer models to spinal cord chips for modeling sporadic ALS. Download your copy today! emulatebio.com/resources/emul…

*to the tune of "War, what is it good for?* NAMS! What are they good for? Absolutely EVERYTHING! Check out our latest blog post to learn what #NAMs are and how they're driving a new era of human-relevant decision-making in #drugdiscovery and development! emulatebio.com/new-approach-m…

Built-in incubation, automated imaging, and AI-ready data generation deliver in vivo fidelity at scale. Meet AVA: emulatebio.com/ava

ICYMI: This month, we heralded in the future of human-centric drug development with the launch of the AVA Emulation System, a first-of-its-kind high-throughput Organ-Chip platform. emulatebio.com/press/emulate-…

🧠 We're only 5 days away from our next webinar! Join us on May 27 as Dr. Clive Svendsen from Cedars-Sinai presents his work using Organ-Chips and iPSCs to model multiple neurological diseases, including ALS, Parkinson’s disease, and FTD. Register now! emulatebio.com/event/using-or…

A new era of drug development: Read our latest press release to learn why we believe the FDA's groundbreaking plan to reduce #animaltesting is a pivotal step forward for patients, researchers, and the entire healthcare ecosystem. emulatebio.com/press/emulate-…

@InVitroFuture @anshulkundaje We like to think that good science never goes out of style!

@anshulkundaje Bit outdated already, but this is a great worked example of how the sensitivity, specificity, and cost profile of microfluidic liver chips as of 2022 makes them realistically worthwhile for early drug candidate screening nature.com/articles/s4385…

Organoid experts - can you point me to some papers that show that they can now be used or hypothesize how they could be used in the future as substitutes for animal studies for testing drugs? I'm trying to understand how many of the new FDA proposals are based on actual evidence